ID

39247

Descripción

The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01679652

Link

https://clinicaltrials.gov/show/NCT01679652

Palabras clave

Versiones (1)
  1. 11/12/19 11/12/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

11 de diciembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Essential Hypertension NCT01679652

Inglés

Eligibility Essential Hypertension NCT01679652

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
increased blood pressure (above 135 mmhg systolic or 85 mmhg diastolic in day time in 24 hour blood pressure measurement taking 5 or 10 mg amlodipine
Descripción

Hypertensive disease | Systolic Pressure Daytime | Diastolic blood pressure Daytime | 24 hour blood pressure | Amlodipine Dose

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2,1]
C0871470
UMLS CUI [2,2]
C0332169
UMLS CUI [3,1]
C0428883
UMLS CUI [3,2]
C0332169
UMLS CUI [4]
C1282173
UMLS CUI [5,1]
C0051696
UMLS CUI [5,2]
C0178602
men and women
Descripción

Gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
age 40 - 70 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
diabetes mellitus
Descripción

Diabetes Mellitus

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011849
glomerular filtration rate < 30 ml/min
Descripción

Glomerular Filtration Rate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0017654
albuminuria > 1,5 g/l
Descripción

Albuminuria

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001925
renogram which suggests secondary hypertension
Descripción

Renography Suggestive of Secondary hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0205917
UMLS CUI [1,2]
C0332299
UMLS CUI [1,3]
C0155616
clinical signs of pheochromocytoma or increased p-metanephrines
Descripción

Sign or Symptom Pheochromocytoma | METANEPHRINE INCREASED

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3540840
UMLS CUI [1,2]
C0031511
UMLS CUI [2]
C0746561
clinical important sign og heart, lung, liver, thyroid or neoplastic diseases
Descripción

Sign or Symptom Heart Diseases | Sign or Symptom Lung diseases | Sign or Symptom Liver diseases | Sign or Symptom Thyroid Diseases | Sign or Symptom Neoplastic disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3540840
UMLS CUI [1,2]
C0018799
UMLS CUI [2,1]
C3540840
UMLS CUI [2,2]
C0024115
UMLS CUI [3,1]
C3540840
UMLS CUI [3,2]
C0023895
UMLS CUI [4,1]
C3540840
UMLS CUI [4,2]
C0040128
UMLS CUI [5,1]
C3540840
UMLS CUI [5,2]
C1882062
clinical important deviations in routine blood samples or ecg
Descripción

Blood specimen Abnormality ECG

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0178913
UMLS CUI [1,2]
C1704258
UMLS CUI [1,3]
C1623258
drug or alcohol abuse
Descripción

Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038586
pregnancy or nursery
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
intolerance to nebivolol
Descripción

Intolerance to Nebivolol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0068475
blood donation with a month of the first examination day
Descripción

Blood Donation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005794
inacceptable increase in blood pressure durin l-nmma infusion (200/120)
Descripción

Increase in blood pressure Unacceptable | Relationship L-NMMA Infusion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0497247
UMLS CUI [1,2]
C1883420
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C0069477
UMLS CUI [2,3]
C0574032
inacceptable side effects to amlodipine
Descripción

Adverse effects Unacceptable Amlodipine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0879626
UMLS CUI [1,2]
C1883420
UMLS CUI [1,3]
C0051696
blood pressure increase above 170/105 on highest dose amlodipine (10 mg)
Descripción

Increase in blood pressure | Etiology Amlodipine High dose

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0497247
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0051696
UMLS CUI [2,3]
C0444956
Volver a la parte superior de la página

Similar models

Eligibility Essential Hypertension NCT01679652

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Hypertensive disease | Systolic Pressure Daytime | Diastolic blood pressure Daytime | 24 hour blood pressure | Amlodipine Dose
Item
increased blood pressure (above 135 mmhg systolic or 85 mmhg diastolic in day time in 24 hour blood pressure measurement taking 5 or 10 mg amlodipine
boolean
C0020538 (UMLS CUI [1])
C0871470 (UMLS CUI [2,1])
C0332169 (UMLS CUI [2,2])
C0428883 (UMLS CUI [3,1])
C0332169 (UMLS CUI [3,2])
C1282173 (UMLS CUI [4])
C0051696 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
Gender
Item
men and women
boolean
C0079399 (UMLS CUI [1])
Age
Item
age 40 - 70 years
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus
Item
diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Glomerular Filtration Rate
Item
glomerular filtration rate < 30 ml/min
boolean
C0017654 (UMLS CUI [1])
Albuminuria
Item
albuminuria > 1,5 g/l
boolean
C0001925 (UMLS CUI [1])
Renography Suggestive of Secondary hypertension
Item
renogram which suggests secondary hypertension
boolean
C0205917 (UMLS CUI [1,1])
C0332299 (UMLS CUI [1,2])
C0155616 (UMLS CUI [1,3])
Sign or Symptom Pheochromocytoma | METANEPHRINE INCREASED
Item
clinical signs of pheochromocytoma or increased p-metanephrines
boolean
C3540840 (UMLS CUI [1,1])
C0031511 (UMLS CUI [1,2])
C0746561 (UMLS CUI [2])
Sign or Symptom Heart Diseases | Sign or Symptom Lung diseases | Sign or Symptom Liver diseases | Sign or Symptom Thyroid Diseases | Sign or Symptom Neoplastic disease
Item
clinical important sign og heart, lung, liver, thyroid or neoplastic diseases
boolean
C3540840 (UMLS CUI [1,1])
C0018799 (UMLS CUI [1,2])
C3540840 (UMLS CUI [2,1])
C0024115 (UMLS CUI [2,2])
C3540840 (UMLS CUI [3,1])
C0023895 (UMLS CUI [3,2])
C3540840 (UMLS CUI [4,1])
C0040128 (UMLS CUI [4,2])
C3540840 (UMLS CUI [5,1])
C1882062 (UMLS CUI [5,2])
Blood specimen Abnormality ECG
Item
clinical important deviations in routine blood samples or ecg
boolean
C0178913 (UMLS CUI [1,1])
C1704258 (UMLS CUI [1,2])
C1623258 (UMLS CUI [1,3])
Substance Use Disorders
Item
drug or alcohol abuse
boolean
C0038586 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or nursery
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Intolerance to Nebivolol
Item
intolerance to nebivolol
boolean
C1744706 (UMLS CUI [1,1])
C0068475 (UMLS CUI [1,2])
Blood Donation
Item
blood donation with a month of the first examination day
boolean
C0005794 (UMLS CUI [1])
Increase in blood pressure Unacceptable | Relationship L-NMMA Infusion
Item
inacceptable increase in blood pressure durin l-nmma infusion (200/120)
boolean
C0497247 (UMLS CUI [1,1])
C1883420 (UMLS CUI [1,2])
C0439849 (UMLS CUI [2,1])
C0069477 (UMLS CUI [2,2])
C0574032 (UMLS CUI [2,3])
Adverse effects Unacceptable Amlodipine
Item
inacceptable side effects to amlodipine
boolean
C0879626 (UMLS CUI [1,1])
C1883420 (UMLS CUI [1,2])
C0051696 (UMLS CUI [1,3])
Increase in blood pressure | Etiology Amlodipine High dose
Item
blood pressure increase above 170/105 on highest dose amlodipine (10 mg)
boolean
C0497247 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C0051696 (UMLS CUI [2,2])
C0444956 (UMLS CUI [2,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial